On Tuesday, Apogee Therapeutics Inc (NASDAQ: APGE) opened higher 5.32% from the last session, before settling in for the closing price of $41.35. Price fluctuations for APGE have ranged from $26.20 to $63.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -33.60% at the time writing. With a float of $37.32 million, this company’s outstanding shares have now reached $46.04 million.
The firm has a total of 196 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Apogee Therapeutics Inc (APGE) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Apogee Therapeutics Inc is 37.32%, while institutional ownership is 88.24%. The most recent insider transaction that took place on Jun 04 ’25, was worth 100,716. In this transaction Chief Medical Officer of this company sold 2,725 shares at a rate of $36.96, taking the stock ownership to the 241,723 shares. Before that another transaction happened on May 07 ’25, when Company’s Chief Medical Officer sold 2,725 for $35.75, making the entire transaction worth $97,419. This insider now owns 244,448 shares in total.
Apogee Therapeutics Inc (APGE) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -33.60% per share during the next fiscal year.
Apogee Therapeutics Inc (NASDAQ: APGE) Trading Performance Indicators
Check out the current performance indicators for Apogee Therapeutics Inc (APGE). In the past quarter, the stock posted a quick ratio of 15.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.54, a number that is poised to hit -1.09 in the next quarter and is forecasted to reach -5.51 in one year’s time.
Technical Analysis of Apogee Therapeutics Inc (APGE)
Analysing the last 5-days average volume posted by the [Apogee Therapeutics Inc, APGE], we can find that recorded value of 0.69 million was better than the volume posted last year of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 49.50%.
During the past 100 days, Apogee Therapeutics Inc’s (APGE) raw stochastic average was set at 94.04%, which indicates a significant increase from 87.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.74% in the past 14 days, which was lower than the 67.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.43, while its 200-day Moving Average is $43.65. Now, the first resistance to watch is $45.06. This is followed by the second major resistance level at $46.57. The third major resistance level sits at $48.53. If the price goes on to break the first support level at $41.59, it is likely to go to the next support level at $39.63. Should the price break the second support level, the third support level stands at $38.12.
Apogee Therapeutics Inc (NASDAQ: APGE) Key Stats
There are currently 46,047K shares outstanding in the company with a market cap of 2.59 billion. Presently, the company’s annual sales total 0 K according to its annual income of -182,150 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -55,340 K.
